Furthermore, blocking transforming growth factor-β (TGF-β) signaling in mice leads to a substantial influx of CD11b+/Ly6G+ neutrophils, which significantly decelerates tumor growth through CD8+ T-cell activation [39]. The gene discussed is CD8A; the disease is neoplasm.